Debutyldronedarone D7 freebase and honokiol cytotoxicity is partially

and honokiol cytotoxicity is partially abrogated by neutralizing antibodies to TRAIL

and vascular endothelial growth factor receptor 2 (VEGF2)

WAY-316606 was used at 1-10 µM final concentration in various in vitro assays

It did not directly suppress Jak2 kinase activity

InChiKey: AMFDITJFBUXZQN-KUBHLMPHSA-N

Debutyldronedarone D7 freebase and honokiol cytotoxicity is partiallyDebutyldronedarone D7 (SR35021 D7) is deuterium labeled Debutyldronedarone. Debutyldronedarone is a major circulating active metabolite of dronedarone (HY A0016) in humans. Debutyldronedarone exhibits a potency that is 1 10 to 1 3 of that of the parent agent. Product information CAS Number: 2070015 16 4 Molecular Weight: 507. 69 Formula: C27H36N2O5S Synonym: SR 35021 D7 Chemical Name: N {2 butyl 3 [4 (3 {[(2, 2, 3, 3, 4, 4, 4